Psychotropics in pregnancy: weighing the risks.

Simple item page
dc.contributor.authorGrover, Sandeepen_US
dc.contributor.authorAvasthi, Ajiten_US
dc.contributor.authorSharma, Yogeshen_US
dc.date.accessioned2006-04-20en_US
dc.date.accessioned2009-05-27T08:37:14Z
dc.date.available2006-04-20en_US
dc.date.available2009-05-27T08:37:14Z
dc.date.issued2006-04-20en_US
dc.description126 references.en_US
dc.description.abstractWith increase in the use of newer psychotropics, there is a growing concern in relation to the teratogenicity. Unfortunately, it is not possible to carry out prospective studies in pregnant women and as a result physicians caring for such patients have to rely on case reports, case series, and retrospective studies. Available evidence shows that the safety of psychotropics in pregnancy is still unresolved and the decision to prescribe psychotropics in pregnancy should be taken in the light of severity of mental disease, and drugs should be prescribed only when the potential risk to the foetus from exposure is outweighed by the risk of untreated maternal disorder. In this review we discussed the current evidence of the teratogenic risks with psychotropic drugs commonly used to treat psychiatric disorders and also focused on decision making in such patients.en_US
dc.description.affiliationDepartment of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India.en_US
dc.identifier.citationGrover S, Avasthi A, Sharma Y. Psychotropics in pregnancy: weighing the risks. Indian Journal of Medical Research. 2006 Apr; 123(4): 497-512en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/25076
dc.language.isoengen_US
dc.source.urihttps://icmr.nic.in/ijmr/ijmr.htmen_US
dc.subject.meshAbnormalities, Drug-Induced --etiologyen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAnticonvulsants --adverse effectsen_US
dc.subject.meshAntidepressive Agents --adverse effectsen_US
dc.subject.meshAntipsychotic Agents --adverse effectsen_US
dc.subject.meshBenzodiazepines --adverse effectsen_US
dc.subject.meshBipolar Disorder --complicationsen_US
dc.subject.meshDepressive Disorder --complicationsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfant, Newbornen_US
dc.subject.meshLithium --adverse effectsen_US
dc.subject.meshMental Disorders --complicationsen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy Complications --drug therapyen_US
dc.subject.meshPsychotropic Drugs --adverse effectsen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshSafetyen_US
dc.subject.meshSchizophrenia --complicationsen_US
dc.titlePsychotropics in pregnancy: weighing the risks.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Medical Research